| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |